Breast cancer
Epithelial to mesenchymal transition (EMT)
Resistin
Journal
Data in brief
ISSN: 2352-3409
Titre abrégé: Data Brief
Pays: Netherlands
ID NLM: 101654995
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
27
04
2019
revised:
22
05
2019
accepted:
29
05
2019
entrez:
17
8
2019
pubmed:
17
8
2019
medline:
17
8
2019
Statut:
epublish
Résumé
Resistin is an adipokine produced by the white adipocytes and adipose-derived macrophages, which mediates inflammation and insulin resistance Huang et al., 1997 and Renehan et al., 2008 Feb. Here, we provide data on the effect of resistin on epithelial to mesenchymal transition (EMT) in breast cancer cells
Identifiants
pubmed: 31417946
doi: 10.1016/j.dib.2019.104118
pii: S2352-3409(19)30472-X
pii: 104118
pmc: PMC6690660
doi:
Types de publication
Journal Article
Langues
eng
Pagination
104118Références
Mol Cell Biol. 2005 Feb;25(4):1569-75
pubmed: 15684405
Lancet. 2008 Feb 16;371(9612):569-78
pubmed: 18280327
Prostate. 2010 Dec 1;70(16):1768-77
pubmed: 20564361
Vet J. 2012 Feb;191(2):203-7
pubmed: 21330172
Mol Oncol. 2014 May;8(3):565-80
pubmed: 24508063
Cell Physiol Biochem. 2014;34(2):368-82
pubmed: 25059120
Sci Rep. 2017 Jan 18;7:40681
pubmed: 28098169
Cytokine. 2019 Aug;120:155-164
pubmed: 31085453
JAMA. 1997 Nov 5;278(17):1407-11
pubmed: 9355998